Vident Investment Advisory, LLC Abbott Laboratories Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $2.49 Million - $2.78 Million	24,727 Added 10.89%	251,735 $27.4 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $10.7 Million - $12.6 Million	110,597 Added 95.01%	227,008 $23 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $8.46 Million - $9.93 Million	89,048 Added 325.43%	116,411 $12.8 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.94 Million - $2.24 Million	20,004 Added 271.83%	27,363 $2.29 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $1.08 Million - $1.3 Million	-10,543 Reduced 58.89%	7,359 $800,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $976,011 - $1.19 Million	-8,560 Reduced 32.35%	17,902 $2.12 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $758,223 - $928,401	6,563 Added 32.98%	26,462 $3.73 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $468,156 - $517,917	4,013 Added 25.26%	19,899 $2.35 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $137,527 - $161,889	1,300 Added 8.91%	15,886 $1.84 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $311,064 - $366,481	2,858 Added 24.37%	14,586 $1.75 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $146,370 - $159,501	1,394 Added 13.49%	11,728 $1.28 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $70,746 - $85,915	772 Added 8.07%	10,334 $1.12 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $1.1 Million - $1.41 Million	-14,403 Reduced 60.1%	9,562 $874,000
Q2 2020 Jul 17, 2020	BUY	$76.57 - $98.0 $1.54 Million - $1.97 Million	20,063 Added 514.17%	23,965 $2.19 Million
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $245,123 - $358,437	3,902 New	3,902 $308,000
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $599,887 - $650,464	-7,330 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $37,897 - $44,200	520 Added 7.64%	7,330 $616,000
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $266,204 - $321,841	4,020 Added 144.09%	6,810 $544,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $182,912 - $207,213	2,790 New	2,790 $202,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $391,920 - $443,113	-6,965 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $63,664 - $68,159	-1,186 Reduced 14.55%	6,965 $397,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $391,737 - $437,219	8,151	8,151 $435,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.9 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.6 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.11 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.81 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.33 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account